Glucocorticoids inhibit calcium- and calcineurin-dependent activation of the human IL-4 promoter

J Immunol. 2000 Jan 15;164(2):825-32. doi: 10.4049/jimmunol.164.2.825.

Abstract

The mechanism by which glucocorticoids (GC) inhibit IL-4 gene expression is currently unknown. In T lymphocytes, IL-4 gene expression is regulated at the level of transcription by increases in intracellular calcium concentration and by the calcium-activated phosphatase calcineurin. In this paper we report that dexamethasone (Dex) inhibits calcium ionophore-induced activation of the human IL-4 promoter in transiently transfected Jurkat T cells. Inhibition of the promoter by Dex is dependent on expression of the GC receptor (GR), because it does not occur in GR-deficient cells. Dex also represses activation of the promoter induced by cotransfecting cells with a constitutively active mutant of calcineurin. Using a series of deletion constructs, we show that the proximal 95 bp of the IL-4 promoter contain a Dex-sensitive regulatory element. This region contains the P1 sequence, a proximal binding site for NF-AT. A calcium-induced but Dex-inhibited nuclear complex containing NF-AT binds to the P1 element in EMSA. Using immunoprecipitation under nondenaturing conditions, we found that the GRalpha isoform coprecipitates with NF-ATc in nuclear extracts of calcium ionophore- and Dex-treated cells. Taken together, our results show that GC inhibit IL-4 gene expression by interfering with NF-AT-dependent transactivation of the proximal human IL-4 promoter.

Publication types

  • Research Support, Non-U.S. Gov't
  • Research Support, U.S. Gov't, P.H.S.

MeSH terms

  • Base Composition
  • Calcineurin / metabolism
  • Calcineurin / physiology*
  • Calcineurin Inhibitors
  • Calcium / antagonists & inhibitors
  • Calcium / physiology*
  • Cell Nucleus / drug effects
  • Cell Nucleus / metabolism
  • DNA-Binding Proteins / antagonists & inhibitors
  • DNA-Binding Proteins / biosynthesis
  • DNA-Binding Proteins / genetics
  • DNA-Binding Proteins / metabolism
  • Dexamethasone / pharmacology*
  • Enzyme Activation / genetics
  • Enzyme Activation / immunology
  • Humans
  • Immunosuppressive Agents / pharmacology*
  • Interleukin-4 / genetics*
  • Interleukin-4 / metabolism
  • Jurkat Cells
  • Lymphocyte Activation / drug effects*
  • NFATC Transcription Factors
  • Nuclear Proteins*
  • Promoter Regions, Genetic / drug effects
  • Promoter Regions, Genetic / immunology*
  • Protein Kinase C / antagonists & inhibitors
  • Protein Kinase C / physiology
  • Response Elements / drug effects
  • Response Elements / immunology
  • Transcription Factors / antagonists & inhibitors
  • Transcription Factors / biosynthesis
  • Transcription Factors / genetics
  • Transcription Factors / metabolism
  • Transfection

Substances

  • Calcineurin Inhibitors
  • DNA-Binding Proteins
  • Immunosuppressive Agents
  • NFATC Transcription Factors
  • Nuclear Proteins
  • Transcription Factors
  • Interleukin-4
  • Dexamethasone
  • Protein Kinase C
  • Calcineurin
  • Calcium